These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31737616)

  • 41. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
    Baker KA; Hong M; Sadi D; Mendez I
    Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
    Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?
    Vilaça-Faria H; Salgado AJ; Teixeira FG
    Cells; 2019 Feb; 8(2):. PubMed ID: 30717429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dickkopf 3 Promotes the Differentiation of a Rostrolateral Midbrain Dopaminergic Neuronal Subset In Vivo and from Pluripotent Stem Cells In Vitro in the Mouse.
    Fukusumi Y; Meier F; Götz S; Matheus F; Irmler M; Beckervordersandforth R; Faus-Kessler T; Minina E; Rauser B; Zhang J; Arenas E; Andersson E; Niehrs C; Beckers J; Simeone A; Wurst W; Prakash N
    J Neurosci; 2015 Sep; 35(39):13385-401. PubMed ID: 26424886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.
    Offen D; Barhum Y; Levy YS; Burshtein A; Panet H; Cherlow T; Melamed E
    J Neural Transm Suppl; 2007; (72):133-43. PubMed ID: 17982886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on the levels of DA and metabolite in striatum in rats with Parkinson's disease treated by BDNF gene modified bone mesenchymal stem cells].
    Zhao GY; Cui L; Gao J; Dai RT; Zhang P
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Jan; 29(1):82-5. PubMed ID: 23662416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease.
    Calice da Silva C; Azevedo BN; Machado DC; Zimmer ER; Martins LAM; da Costa JC
    Behav Brain Res; 2017 May; 324():30-40. PubMed ID: 28167338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transplantation of Flk-1+ human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and anti-inflammatory and angiogenesis effects in an intracerebral hemorrhage rat model.
    Bao XJ; Liu FY; Lu S; Han Q; Feng M; Wei JJ; Li GL; Zhao RC; Wang RZ
    Int J Mol Med; 2013 May; 31(5):1087-96. PubMed ID: 23468083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease.
    Park HJ; Lee PH; Bang OY; Lee G; Ahn YH
    J Neurochem; 2008 Oct; 107(1):141-51. PubMed ID: 18665911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative characterization of stem cells from human exfoliated deciduous teeth, dental pulp, and bone marrow-derived mesenchymal stem cells.
    Kunimatsu R; Nakajima K; Awada T; Tsuka Y; Abe T; Ando K; Hiraki T; Kimura A; Tanimoto K
    Biochem Biophys Res Commun; 2018 Jun; 501(1):193-198. PubMed ID: 29730288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. hTERT- and hCTLA4Ig-expressing human bone marrow-derived mesenchymal stem cells: in vitro and in vivo characterization and osteogenic differentiation.
    Dai F; Yang S; Zhang F; Shi D; Zhang Z; Wu J; Xu J
    J Tissue Eng Regen Med; 2017 Feb; 11(2):400-411. PubMed ID: 25047146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats.
    Bao X; Wei J; Feng M; Lu S; Li G; Dou W; Ma W; Ma S; An Y; Qin C; Zhao RC; Wang R
    Brain Res; 2011 Jan; 1367():103-13. PubMed ID: 20977892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.